Navigation Links
Systemic Corticosteroid Therapy can be used for treating all types of Infectious Mononucleosis

Scott Thompson and colleagues from University of Rochester Medical Center, has found from review of records of patients treated with corticosteroids that Corticosteroids is the most effective and useful treatment// option for Infectious mononucleosis, including severe airway compromise mononucleosis. The results of the study have been published in Achieves of Otolaryngology – Head and Neck Surgery, JAMA Journal. The researcher’s analyzed data of patients treated for Infectious mononucleosis with corticosteroids from January 1998 to March 2003. The results of the study disapproved earlier controversies over the usage of systemic corticosteroids for infectious mononucleosis.

The study review showed that Corticosteroid therapy was used in 92 patients with infectious mononucleosis of the total 206 patients with infectious mononucleosis. These results show that there was an increase in doctors treating patients with infectious mononucleosis with corticosteroids. The patients were follow up for disease prognosis during regular physician visits, inpatient admissions and during consultations.

Dr. Scott Thompson said, “Despite consistent and uniform acceptance in the medical literature that SCT in the setting of IM [infectious mononucleosis] should be reserved for patients with impending airway obstruction, corticosteroids continue to be used on a much broader scale at this tertiary care institution and this observation suggests that clinicians see value in SCT for treatment of IM beyond the classically accepted reasons. Moreover, despite previous reports of possible adverse consequences of SCT in IM, our review failed to demonstrate any such trend.”

Source: News wie
'"/>




Page: 1

Related medicine news :

1. Systemic Pre-Surgical Treatment Can Prolong Survival Of Kidney Cancer Patients
2. New Treatment Offers Hope for Systemic Sclerosis
3. Corticosteroids Safe for Bones
4. Corticosteroids Safe for Bones
5. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
6. The Effectiveness Of Inhaled Corticosteroids Studied
7. The Effectiveness Of Inhaled Corticosteroids Studied
8. Inhaled Corticosteroids Reduce Death in Patients with COPD
9. Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis
10. High-dose Inhaled Corticosteroid Use for COPD Could Cut Risk of Lung Cancer
11. High Dose Inhaled Corticosteroid Use for COPD Could Cut Risk of Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... 2016 , ... On Tuesday, April 26, 2016 members of the HomeTown Health ... Gov. Nathan Deal on SB 258, the “Rural Health Care Relief” Bill. , The ... tax credit to individuals and corporations which donate directly to a “rural hospital” in ...
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart is celebrating ... new location in the Exchange Furniture Mall at 112 Vilseck Road in Fort Stewart. ... Smart TV. Plus attendees will have the opportunity to meet general dentists Thomas Richards, ...
(Date:4/29/2016)... NY (PRWEB) , ... April 29, 2016 , ... ... and engineer of patented products, announces the Gyrociser, an exercise invention which aids ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly ... for the head and neck/ear, nose and throat specialty, has added the KOTLER NASAL ... KOTLER NASAL AIRWAY™ is a newly patented safety device secured by nasal surgeons ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... enterprise focused entirely on patients with cancer, today announced that Lynne Malestic, RN, ... the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... , April 29, 2016  In the ... projected to shift from systems dependent on CRTs monitors ... types of modality CRT Medical monitors and will ... are a host of foreseeable benefits to this ... will existing modalities have to be replaced in ...
(Date:4/29/2016)... ReportsnReports.com adds "Pulmonary Arterial ... report that provides an overview of the PAH ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Pulmonary Arterial ...
(Date:4/29/2016)... Jersey , April 29, 2016 ... Suite for Life Sciences, Product Development Capabilities in ... Life Science Customer Base . ... provider, today announced the acquisition of Skura Corporation,s ... global leader in adaptive sales enablement technology for ...
Breaking Medicine Technology: